Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

225Ac PTR 58 - Starget Pharma

Next Previous
Drug Profile

225Ac PTR 58 - Starget Pharma

Alternative Names: 225Ac PTR 58; 225Actinium PTR-58; PTR-58 [225Ac]

Latest Information Update: 25 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Starget Pharma
  • Class Antineoplastics; Cyclic peptides; Drug conjugates; Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Ionising radiation emitters; Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Liver cancer; Malignant melanoma; Neuroendocrine carcinoma; Sarcoma

Most Recent Events

  • 27 Mar 2025 Starget Pharma has patents pending for 'Conformational constrained somatostatin receptor 3 peptide ligands and their conjugates and uses thereof' in USA
  • 27 Mar 2025 Preclinical trials in Liver cancer (Diagnosis) in Israel (unspecified route) prior to March 2025 (Starget pharma pipeline, March 2025)
  • 27 Mar 2025 Preclinical trials in Liver cancer in Israel (unspecified route) prior to March 2025 (Starget pharma pipeline, March 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top